Tech support
Shopping Cart
Login
Register
Forgot Password?
Products
Diagnostics
Suppliers
About us
Contact
+31 (0)26 326 4450
Find the product you need
Description
Catalog number
CAS No.
Clone ID
News
Vorige
Volgende
InVivoPlus anti-mouse TIM-3 (CD366)
Catalog number:
BP0115_100mg
Brand:
Bio X Cell
Packing:
100 mg
Other sizes:
Other sizes available
Price:
€ 4062.00
Expected delivery time:
7 days
Quantity:
Spin Up
Spin Down
General
References
Product specifications for - InVivoPlus anti-mouse TIM-3 (CD366)
Promotion:
Promotion:
The price displayed is only for academic or non-profit organizations. Please
contact our helpdesk
for regular prices.
Overview:
Product group:
Antibodies
Category:
Primary Antibodies
Application:
Flow Cytometry; Neutralisation/Blocking
Host:
Rat
Clonality:
Monoclonal
Isotype:
IgG2a Kappa
Properties:
Molecular weight:
150 kDa
Datasheet:
Datasheet
Research Use Only
UNSPSC:
12352203
Concentration:
2-10 mg/ml
Scientific information:
Clone ID:
RMT3-23
Related products:
Related products:
Recommended Isotype Control(s):
InVivoPlus rat IgG2a isotype control (BP0089)
Recommended Dilution Buffer:
InVivoPure pH 7.0 Dilution Buffer (IP0070)
Additional information:
Synonyms:
RMT3-23; BP0115; HAVCR2 / TIM-3; HAVCR2; Tim-3; TIMD3; TIMD-3; TIM3; KIM-3; HAVcr-2; kidney injury molecule-3; T-cell membrane protein 3; T-cell immunoglobulin mucin receptor 3; T-cell immunoglobulin and mucin domain-containing protein 3; T cell immunoglobulin mucin-3; T cell immunoglobulin mucin 3; hepatitis A virus cellular receptor 2; BioXCell
Kurtulus S, Sakuishi K, Ngiow SF, et al. TIGIT predominantly regulates the immune response via regulatory T cells. J Clin Invest. 2015;125(11):4053-62.
Read more
Ngiow SF, Young A, Jacquelot N, et al. A Threshold Level of Intratumor CD8+ T-cell PD1 Expression Dictates Therapeutic Response to Anti-PD1. Cancer Res. 2015;75(18):3800-11.
Read more
Tripathi S, Chabtini L, Dakle PJ, et al. Effect of TIM-3 Blockade on the Immunophenotype and Cytokine Profile of Murine Uterine NK Cells. PLoS ONE. 2015;10(4):e0123439.
Read more
Erickson JJ, Rogers MC, Hastings AK, Tollefson SJ, Williams JV. Programmed death-1 impairs secondary effector lung CD8⁺ T cells during respiratory virus reinfection. J Immunol. 2014;193(10):5108-17.
Read more
Mittal D, Young A, Stannard K, et al. Antimetastatic effects of blocking PD-1 and the adenosine A2A receptor. Cancer Res. 2014;74(14):3652-8.
Read more
Dolina JS, Braciale TJ, Hahn YS. Liver-primed CD8+ T cells suppress antiviral adaptive immunity through galectin-9-independent T-cell immunoglobulin and mucin 3 engagement of high-mobility group box 1 in mice. Hepatology. 2014;59(4):1351-65.
Read more
Dietze KK, Zelinskyy G, Liu J, Kretzmer F, Schimmer S, Dittmer U. Combining regulatory T cell depletion and inhibitory receptor blockade improves reactivation of exhausted virus-specific CD8+ T cells and efficiently reduces chronic retroviral loads. PLoS Pathog. 2013;9(12):e1003798.
Read more
Mcgray AJ, Hallett R, Bernard D, et al. Immunotherapy-induced CD8+ T cells instigate immune suppression in the tumor. Mol Ther. 2014;22(1):206-18.
Read more
Zelinskyy G, Myers L, Dietze KK, et al. Virus-specific CD8+ T cells upregulate programmed death-1 expression during acute friend retrovirus infection but are highly cytotoxic and control virus replication. J Immunol. 2011;187(7):3730-7.
Read more
See All